Samalin Investment Counsel, LLC
Source: SEC Form 13F · as of Mar 2026Samalin Investment Counsel, LLC holds 16 biotech & pharma companies tracked by BioSniper, totaling $10.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$10.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 6,516 | $1.6M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 5,380 | $1.5M |
| MRKMerck & Co., Inc. | 11,421 | $1.4M |
| LLYELI LILLY & Co | 840 | $772K |
| PFEPFIZER INC | 26,913 | $756K |
| ABBVAbbVie Inc. | 3,454 | $751K |
| AMGNAMGEN INC | 1,958 | $689K |
| ANIPANI PHARMACEUTICALS INC | 7,864 | $605K |
| ABTABBOTT LABORATORIES | 3,899 | $400K |
| REGNREGENERON PHARMACEUTICALS, INC. | 511 | $395K |
| NVONovo Nordisk A/S | 10,006 | $368K |
| BMYBRISTOL MYERS SQUIBB CO | 5,527 | $335K |
| IDXXIDEXX LABORATORIES INC /DE | 431 | $242K |
| ELVElevance Health Inc. | 704 | $206K |
| NKTXNkarta, Inc. | 93,819 | $198K |
| OSCROscar Health Inc. | 12,091 | $139K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.